Guardant Health
GH
#1097
Rank
โ‚น2.064 T
Marketcap
โ‚น15,567
Share price
-3.49%
Change (1 day)
266.63%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Market capitalization of Guardant Health (GH)

Market cap: โ‚น2.064 Trillion

As of July 2026 Guardant Health has a market cap of โ‚น2.064 Trillion. This makes Guardant Health the world's 1097th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Guardant Health from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น2.064 T71.93%
2025โ‚น1.200 T272.12%
2024โ‚น322.64 B18.04%
2023โ‚น273.33 B18.55%
2022โ‚น230.56 B-69.53%
2021โ‚น756.79 B-19.69%
2020โ‚น942.29 B80.08%
2019โ‚น523.26 B132.16%
2018โ‚น225.39 B

End of Day market cap according to different sources

On Jul 7th, 2026 the market cap of Guardant Health was reported to be:

โ‚น2.064 Trillion
by Nasdaq info icon info icon
โ‚น2.064 Trillion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Neogen
NEOG
โ‚น195.29 B-90.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
โ‚น3.848 T 86.46%๐Ÿ‡บ๐Ÿ‡ธ USA